Bristol-Myers Squibb CompanyBMYNYSE
Loading
Debt to Equity Over TimeElevated
Percentile Rank93
3Y CAGR+24.9%
5Y CAGR+13.3%
Year-over-Year Change
Debt-to-equity ratio
3Y CAGR
+24.9%/yr
vs +25.8%/yr prior
5Y CAGR
+13.3%/yr
Recent acceleration
Acceleration
-0.9pp
Decelerating
Percentile
P93
Near historical high
vs 5Y Ago
1.9x
Solid growth
Streak
1 yr
Consecutive declineElevated
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 2.55 | -18.6% |
| 2024 | 3.13 | +122.5% |
| 2023 | 1.41 | +7.5% |
| 2022 | 1.31 | +3.3% |
| 2021 | 1.27 | -7.2% |
| 2020 | 1.37 | +48.3% |
| 2019 | 0.92 | +75.9% |
| 2018 | 0.52 | -22.8% |
| 2017 | 0.68 | +63.5% |
| 2016 | 0.41 | - |